Navigation Links
ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World
Date:12/12/2008

ITRI held the 2008 International Symposium on Chronic Hepatitis and Liver Diseases for not only treatment & diagnosis development but prevention on liver diseases studies in Taipei, Taiwan.

(PRWEB) December 12, 2008 -- This year, from December 6th to 7th, the Industrial Technology Research Institute (ITRI) held the 2008 International Symposium on Chronic Hepatitis and Liver Diseases at NTUH International Conference Center. For this symposium, ITRI sincerely invited many international leading experts and authorities to take part in, making the profound discussion about The Current Status of the Treatment for Chronic Hepatitis C Virus Research; the major participants in this conference included Mr. Ya Jin-Chuan, the Deputy Minister of Dept. of Health, Prof. Chen Ding-Sin, the ex-Dean of HTUH, Mr. Liou Jhong-jheng, the Director of ITRI's Biomedical & Engineering Research Laboratories (BERL), David A. Brenner, the Dean of School of Medicine in San Diego University, U.S., Dr. Augusto Villanueva from Span, and Dr. Masahiro Satake, the Director of Red-Cross Blood Center in Japan. More than hundreds of magnates such as authoritative doctors, leading experts, and industrial owners related in liver diseases participated in this symposium, targeting on the two issues; one is about the up-to-date experiences of medicine development & new therapy for hepatitis C, the other is about the current status of prevention & treatment and future research direction for hepatitis C.

''To combine many domestic fundamental studies on anti-hepati
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. United Commercial Bank Extends its Use of Misys Equation and Trade Innovation Systems to Support its Expansion in Taiwan
2. -Ingen Technologies Registers Oxyview(R) in Taiwan-
3. OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan
4. Raw deal for foreign brides in Taiwan: study
5. Nursing homes a popular option in Taiwan
6. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
7. Neuralstem Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials
8. $4 million nursing grant focuses on at-risk premature infants
9. Home Dialysis Clinical Research Study is Underway - Focuses on At-Home Extended Duration Treatment
10. November issue of Reproductive Health Matters focuses on maternal mortality
11. Third Annual Saddleback Global Summit on AIDS & The Church Focuses on Cooperative Leadership:

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World
ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 /PRNewswire-USNewswi...ector and CEO, Natural Products Association ,,...the U.S. Anti-Doping Agency (USADA) to educate con...s selling steroids as dietary supplements, the Nat...trade association representing retailers and manuf...
(Date:12/2/2009)...The longer the drug used, the greater the sleep di...ec. 2 (HealthDay News) -- The widely used club dru...nea, say U.S. researchers. , "People who use ec...n and can cause immediate and dangerous problems s...of the Johns Hopkins School of Medicine in Baltimo...
(Date:12/2/2009)..., , VIRGINIA BEACH, Va., Dec. 2 /PRNewswi...arette. These smokeless cigarettes continue to gro...rket is now available at the PremiumEcigarette - t...tronic cigarette - at the amazingly low price of $...or people to try the e-cigarette at a very low pri...
(Date:12/2/2009)..., ,, NEW YORK, Dec. 2 /PRNewsw...tient palliative care coordination, Advanced Illn...duce hospitalizations in the last years of life as...nd their family caregivers without increasing mort...tudy published in American Journal of Managed Car...
(Date:12/2/2009)... Waltham, MAJoseph Balboni loves sports. An avid ... the 46-year-old insurance agent became increasing... to keratoconus, a degenerative eye disorder. Unab...ed Sox games, he faced the prospect of a corneal t..., Then three years ago, Balboni discovered an alt...
Breaking Medicine News(10 mins):Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Ecstasy Users at Higher Risk of Sleep Apnea 2Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4Health News:Brandeis studies evaluate visionary approach to improving eyesight 2
... "Lifestyle 180" wellness program ...tive lives. The six-week program includes almost ..., exercise, and stress management. The next sessi...consistently sought to shift the national focus fr...
... After a series of tests that scanned and ev...f the Southern Illinois University School of Medic...by far the most reliable computer model for the un...erent computer systems, the IT staff of the Southe...
... Brain Injury Awareness Month emphasizes rol...atients and their families , ...ple experience traumatic brain injuries each year ...nal Brain Injury Awareness Month in March 2009. Or...
...Innovation in Hair Removal since the Original Ligh...NTA CLARA, Calif., March 5 Lumenis Ltd., a global...t-based and radio-frequency devices for surgical, ...duction at the American Academy of Dermatology ann...
...LIKELY IN COPD PATIENTS WITH ACUTE EXACERBATIONS, ...chronic obstructive pulmonary disease (COPD) who a...pulmonary embolism (PE). Researchers from British ...ce of PE during exacerbations of COPD. Overall, th...
...n accepted for publication as an original article ..., , SANTA CLARA, Calif., March 4 NewCardio, Inc....nd services company, today announced that Dr. Ihor... in Orlando on March 29, 2009. , , Dr. Gussak, o...
Other Medicine News:Health News:Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases 2Health News:Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases 3Health News:Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases 4Health News:Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases 5Health News:Top Hospital Switches To Cybernet Compact Computers To Save More Lives 2Health News:Nearly 1.4 Million Sustain Traumatic Brain Injuries Each Year 2Health News:Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction 2Health News:Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction 3Health News:Journal Chest: March news briefs 2Health News:UPDATE: NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 2Health News:UPDATE: NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 3Health News:UPDATE: NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 4
(Date:12/2/2009)... , ROCKVILLE, Md., Dec. 2 /PRNewswire-FirstCall... favorable initial results from the first stage of... safety and immunogenicity of the company,s 2009 H...accine. Novavax is conducting this study in colla...port registration of the vaccine in Mexico and pot...
(Date:12/2/2009)... , NEW YORK, Dec. 2 /PRNewswire-FirstCall/ -...today announced that the U.S. Food and Drug Admini...for KRX-0401 (perifosine), the Company,s novel, po...hat inhibits the phosphoinositide 3-kinase (PI3K)/...ory multiple myeloma. ,, The Fast Track progr...
(Date:12/2/2009)... , BIRMINGHAM, Ala., Dec. 2 A... diagnosed with cancer. For adults 65 and over, th...the odds of a man developing prostate cancer are o...ncer are one in nine. Vision loss threatens the o...sk of injuries, depression and inability to comple...
Breaking Medicine Technology:NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2HMS Holdings Corp Hosts Second Quarter 2009 Financial Teleconference and Presentation 51790 1HMS Holdings Corp Hosts Second Quarter 2009 Financial Teleconference and Presentation 51790 2Kendle Announces Details Regarding Second Quarter 2009 Earnings Conference Call and Webcast 51787 1Kendle Announces Details Regarding Second Quarter 2009 Earnings Conference Call and Webcast 51787 2New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 1New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 2New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 3New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 4
... a powerful predictor of eventual treatment ... Roche today announced final results from,the REP...once-weekly,PEGASYS(R) (peginterferon alfa-2a) and...romising treatment option for patients whose infec...other pegylated interferon (Peg-,Intron(R), pegint...
...DM Pharma, Inc.,(Nasdaq: IDMI ) today announced u...lanoma vaccine clinical trial (DC-MEL-202). The up...t UVIDEM showed evidence of clinical,activity and ...d in,patients with advanced melanoma. The data ar...nternational Society for Biological Therapy of Can...
Other Medicine Technology:Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin 2Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin 3Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin 4Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin 5Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin 6Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin 7IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients 2IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients 3IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients 4
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: